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Behavioral/Cognitive
Forebrain Deletion of the Vesicular Acetylcholine
Transporter Results in Deficits in Executive Function,
Metabolic, and RNA Splicing Abnormalities in the Prefrontal
Cortex
Benjamin Kolisnyk,1,2Mohammed A. Al-Onaizi,1,4 Pedro H. F. Hirata,1Monica S. Guzman,1,3 Simona Nikolova,1
Shahar Barbash,6Hermona Soreq,6 Robert Bartha,1,5Marco A. M. Prado,1,2,3,4 and Vania F. Prado1,2,3,4
1Robarts Research Institute, 2Graduate Program in Neuroscience, 3Department of Physiology and Pharmacology, 4Department of Anatomy and Cell
Biology, 5Department of Medical Biophysics, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada, N6A
5K8, and 6Department of Biological Chemistry and The Edmond and Lily Safra Center of Brain Science, The Hebrew University of Jerusalem, Jerusalem
91904, Israel
Oneof thekeybrain regions in cognitiveprocessingandexecutive function is theprefrontal cortex (PFC),which receives cholinergic input
from basal forebrain cholinergic neurons. We evaluated the contribution of synaptically released acetylcholine (ACh) to executive
function by genetically targeting the vesicular acetylcholine transporter (VAChT) in the mouse forebrain. Executive function was as-
sessed using a pairwise visual discrimination paradigm and the 5-choice serial reaction time task (5-CSRT). In the pairwise test, VAChT-
deficient mice were able to learn, but were impaired in reversal learning, suggesting that these mice present cognitive inflexibility.
Interestingly, VAChT-targetedmice took longer to reach criteria in the 5-CSRT. Although their performance was indistinguishable from
that of control mice during low attentional demand, increased attentional demand revealed striking deficits in VAChT-deleted mice.
Galantamine, a cholinesterase inhibitor used in Alzheimer’s disease, significantly improved the performance of control mice, but not of
VAChT-deficient mice on the 5-CSRT. In vivomagnetic resonance spectroscopy showed altered levels of two neurochemical markers of
neuronal function, taurine and lactate, suggesting altered PFCmetabolism in VAChT-deficient mice. The PFC of these mice displayed a
drastic reduction in the splicing factor heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNPA2/B1), whose cholinergic-mediated
reduction was previously demonstrated in Alzheimer’s disease. Consequently, several key hnRNPA2/B1 target transcripts involved in
neuronal function present changes in alternative splicing in VAChT-deficientmice, including pyruvate kinaseM, a key enzyme involved
in lactate metabolism. We propose that VAChT-targeted mice can be used to model and to dissect the neurochemical basis of executive
abnormalities.
Introduction
The prefrontal cortex (PFC) is essential for the modulation of
executive function, which is loosely defined as a set of cognitive
tools that allows hierarchical and timely control of actions lead-
ing to specific behaviors (Alvarez and Emory, 2006; Robbins and
Roberts, 2007; Chudasama, 2011). Disruption in executive func-
tion is a key symptom in neurological and neuropsychiatric dis-
orders, including Alzheimer’s disease (AD; Perry and Hodges,
1999; Traykov et al., 2007; McGuinness et al., 2010), schizophre-
nia (Morice, 1990), autism (Hill, 2004; Sala et al., 2011), and drug
addiction (Stalnaker et al., 2009). The basic neurochemical un-
derpinnings of executive function are, however, still poorly
understood.
Cholinergic deficits are a hallmark of AD (Perry et al., 1977;
Whitehouse et al., 1981, 1982). Moreover, amyloid  (A) oli-
gomers, potential toxins in AD, disrupt cholinergic synaptic
transmission in the PFC (Chen et al., 2013). Cholinergic defi-
ciency in AD can have widespread effects, including global
changes in alternative splicing of genes involved in synaptic plas-
ticity (Berson et al., 2012).
Acetylcholine (ACh) in the PFC has been implicated in con-
trolling attention (Elliott, 2003; Jurado andRosselli, 2007), one of
the components of executive function. Cue detection and top-
downmodulation of attentive behavior have both been shown to
activate PFC cholinergic activity and to be modulated by cholin-
ergic signaling (Sarter et al., 2001; Parikh et al., 2007). Cholin-
ergic transients in the PFC have been linked to cue detection, and
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both tonic and phasic PFC ACh release seem to regulate atten-
tional demand (Parikh et al., 2007; for review, see Hasselmo and
Sarter, 2011), which may depend mainly on nicotinic receptor
signaling (McGaughy et al., 1999; Grottick and Higgins, 2000;
Parikh et al., 2010; Guillem et al., 2011).
Cognitive flexibility, the ability to alter strategy according to
changing environmental cues, is another key component of ex-
ecutive function (Elliott, 2003; Jurado and Rosselli, 2007). The
neurochemical basis of cognitive flexibility is not fully under-
stood, but serotonin is thought to play critical roles (Schmitt et
al., 2006; Evers et al., 2007; Brigman et al., 2010).
Release of ACh is a tightly regulated process, with the vesicular
acetylcholine transporter (VAChT) controlling a limiting key
step (de Castro et al., 2009a; Kolisnyk et al., 2013; for review, see
Prado et al., 2013). Genetic elimination of VAChT from the fore-
brain causes deficits in reversal learning assessed using theMorris
Water Maze (MWM) (Martyn et al., 2012). Deficits in reversal
learning may be related to hippocampal dysfunction, but could
also reflect alterations in behavioral flexibility. To examine if de-
creased levels of VAChT, a change observed in AD (Efange et al.,
1997; Chen et al., 2011), affects executive function we have used
touchscreen tasks. We report that elimination of forebrain
VAChT caused severe deficits in cognitive flexibility and in sus-
tained attention. In addition, we found that these mutant mice
have profound changes in RNA processing in the PFC, which
correlate with behavioral andmetabolic deficits. Our results sug-
gest that elimination of forebrain cholinergic activity in mice
provides a model for understanding the neurochemical basis of
executive function.
Materials andMethods
Animals. Generation of VAChTSix3-Cre-flox/flox mice was previously de-
scribed (Martyn et al., 2012). In short, VAChTSix3-Cre-flox/flox mice were
generated by crossing VAChTflox/flox (mixed C57BL/6J  129/SvEv
background, backcrossed to C57BL/6J for five generations) with the
Six3-Cre mouse line (NMRI background, backcrossed to C57BL/6J for
five generations). We then intercrossed VAChTSix3-Cre-flox/wt mice to
obtain VAChTSix3-Cre-flox/flox. For the galantamine experiments, the
mice usedwere wild-type C57BL/6J.Mice were housed in groups of three
or four per cage without environmental enrichment in a temperature-
controlled roomwith 14/10 h light/dark cycle, andwater was provided ad
libitum. Only male mice were used in these studies. Mice were restricted
to 85% of their free-feed weight and maintained on 85% of their weight
for the duration of the study. All procedures were conducted in accor-
dance with guidelines from the Canadian Council of Animal Care at the
University of Western Ontario with an approved institutional animal
protocol (2008–127).
Western blotting. Mouse PFC was collected, protein was isolated, and
immunoblotting was performed as previously described (Martins-Silva
et al., 2011). The antibodies used were anti-VAChT (catalog #139103;
Synaptic Systems) at a 1:3000 dilution, anti-Synaptophysin (catalog
#S5768; Sigma-Aldrich) at a 1:500 dilution, anti-hnRNP A2/B1 (catalog
#sc-10035; Santa Cruz Biotechnology) at a 1:500 dilution, and anti--
Actin (catalog #ab49900; Abcam), at a 1:15000 dilution. Band intensity
was quantified using FluoroChemQ software (Thermo Fisher Scientific).
ACh release. ACh release from prefrontal cortical brain slices was
quantified by labeling slices with [ 3H] methyl-choline before using KCl
to stimulate release of labeled ACh as previously described (Guzman et
al., 2011).
qPCR. To measure mRNA expression, total RNA was extracted from
freshly dissected PFC tissue, using the Aurum Total RNA for fatty and
fibrous tissue kit (Bio-Rad) according to the manufacturer’s instruc-
tions. cDNA synthesis and qPCR analysis were performed as previously
described (Guzman et al., 2011). Primer sequences used to determine
alternative spliced transcripts are found in Table 1. -Actin was used as a
reference transcript for all reactions. For alternative splicing experi-
ments, the alternative exon levels were normalized to a constitutively
expressed exon from the same gene.
Magnetic resonance imaging. Magnetic resonance spectroscopy of the
prefrontal region was performed in four VAChTSix3-Cre-flox/flox mice and
four littermates (VAChTflox/flox). Spectroscopic localization of a 24 l
voxel was achieved by adiabatic selective refocusing (DelaBarre and Gar-
wood, 1998) on a 9.4 tesla horizontal bore small animal Agilentmagnetic
resonance imaging (MRI) scanner. Water-suppressed full spectra (TR/
TE  3250/20 ms, 128 acquisitions), water-suppressed macromolecule
spectra (TR/TE  5000/20 ms, inversion time TI  873 ms, 128 acqui-
sitions), and water-unsuppressed spectra (TR/TE  3250/20 ms, 8 ac-
quisitions) were acquired. All animals were anesthetized with 2%
isoflurane during the procedure and were maintained at 37° by blowing
warm air into the bore of the magnet using a Model 1025 Small Animal
Monitoring and Gating System (SA Instruments).
Metabolite analysis. Magnetic resonance spectra were analyzed using
purpose-built software (fitMAN; Bartha et al., 1999) to determine the
contribution of each metabolite relative to total creatine as previously
described (Bartha, 2007, 2008). Briefly, spectra were lineshape corrected
(Bartha et al., 2000b) and the macromolecule and residual water contri-
butionwas removed (Kassem and Bartha, 2003). Then, the spectrumwas
fitted in the time domain to a basis set of 19 metabolite lineshapes
(Pfeuffer et al., 1999; Bartha et al., 2000a). Five metabolites (measured
relative to creatine) were reliably measured and included in group com-
parisons: N-acetylaspartate (NAA), myo-inositol (Myo), choline (Cho),
taurine (Tau), and lactate (Lac).
Touchscreen behavioral assessment
Apparatus and task.Micewere trained in the 5-choice serial reaction time
task (5-CSRT) and in the pairwise visual discrimination in automated
Bussey–Saksida Mouse Touchscreen Systems model 81426 (Campden
Instruments). Schedules were designed and data were collected using the
ABET II Touch software v.2.15 (Lafayette Instruments).
Pretraining.Before being trained on the pairwise visual discrimination
or the 5-CSRT task, mice were first put through a pretraining program.
This consisted of first habituating the mice to the testing chamber with
the lights off for 15min. The next day,mice were left in the chamber with
the lights off for 20min, this time with the reward tray primed with a 150
l reward (strawberry milkshake; Saputo Dairy Products), and a tone
was played whenever the mouse entered the reward tray. Whenever the
mouse returned to the reward tray, it received a reward (7l) pairedwith
the tone. This training was repeated the next 2 d for 40 min sessions
(phase 1).
The next training phase (phase 2) involved pairing the reward with the
presentation of the stimulus on the touchscreen. The stimulus appeared
randomly in one of the windows and after 30 s, it was removed and a
reward (7 l) was given paired with a tone. If the mouse touched the
screenwhile the imagewas displayed, it immediately received a reward (7
l). Once the mouse collected the reward a new trial was initiated. This
Table 1. Primers for alternative splicing assay
Target Forward primer(53 3) Reverse primer (53 3)
CD55 exon 8 CCCAGCATGTACCTGTTACC TCACATGCAAAACTGTCAAGG
CD55 exon 1 TGTCTCTGTTGCTGCTGTCC TGCTCAGCAAACTTGGAGTG
DRAM2 exon 2 TGATTCAAGGTTCACACTCACA AAAACTGAGGCCTTGCTGAA
DRAM2 exon 4 TTCAGCAAGGCCTCAGTTTT TCAGGAGGTATTGTCCCTGTG
SIPA1L1 intron 5 TCAGGCATGCAGTTCTTTTG GAAAGCAGGCAGTACCTTCG
SIPA1L1 exon 4 TAGTGTGGACGCTGCTGTCT GGCTCTGTGGTCACCAGAAT
DYSTONIN exon 41 ATGGCATTTCCCCCATTAG GGAGGTTGGTTTTGCTTCAA
DYSTONIN exon 7 GAGCGGGACAAAGTTCAAAA CCCGTCCCTCAGATCCTC
REELIN exon 3 ATCATGTCCGACCACCAGTT ATCATGTCCGACCACCAGTT
REELIN exon 18 GCAGTGCCAGACTTTCCTCT GCCTCCCATCTTTGTTGAAA
REELIN exon 1 GGCAACCCCACCTACTACG GACTGGATGCTTGTCGAGGT
mENAH CGGCAGTAAGTCACCTGTCA C TTCAGCTTTGCCAGCTCTT
mENAH invasive GATTCAAGACCATCAGGTTGTG CAATGTTGGCCCTAAATAGAA
PKM1 CATGCAGCACCTGATAGCTC TTATAAGAGGCCTCCACGCTG
PKM2 GCAGTGGGGCCATTATCGT GGGATTTCGAGTCACGGCAA
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phase was repeated until the mouse completed
30 trials within 60 min (phase 2).
Phase 3 was used to further shape behavior.
It involved displaying the stimulus randomly
in one of the windows. The mouse was re-
quired to touch the stimulus on the screen to
receive a reward (7 l) paired with a tone.
There was no response to the mouse touching
anything but the stimulus. Once again, this was
repeated until the mouse completed 30 trials
within 60 min. Phase 4 was identical to phase 3
except that the mouse was required to initiate
each trial by nose poking the reward tray. Cri-
terion was 30 correct trials within 60 min.
Finally, in the last pretraining phase (phase
5), the previous procedure was repeated but if
the mouse touched an incorrect screen, it re-
ceived a 5 s time-out, during which the light
was turned on. The final phase had a stricter
criterion, requiring the mouse to perform 30
trials in 60 min with at least 23 correct re-
sponses in 2 consecutive days.
Pairwise visual discrimination and reversal.
Pairwise visual discrimination and reversal
task were performed as previously described
(Romberg et al., 2013).Mice used in this exper-
iment were 6–8 months old. At the beginning
of each session, the reward tray was primed
with 7 l of milkshake. Briefly, the mice were
first trained to discriminate between two visual
stimuli, which were presented simultaneously,
with their spatial location randomized over a
30 trial session. If mouse nose poked the cor-
rect stimulus (S), a tone was played and
mouse received a reward (7 l), whereas if the
incorrect stimulus (S) was nose poked, light
in the chamber was turned on for 5 s (time-
out) followed by a correction trial. During the
correction trial, the trial was repeated until the
mouse poked the correct stimulus. Criterion
was reached when the mouse selected the cor-
rect image (S) on 80% of the trials, excluding
correction trials, for 2 consecutive days. Once
mice reached criteria, they were given two ses-
sions to assess baseline performance on the
task. For reversal learning the rule associated to
each stimulus was switched, that is, the re-
warded image (S) during acquisition became
the (S) image in reversal and was punished,
while the (S) image from acquisition became
the correct stimulus and was rewarded. Rever-
sal learning was assessed over the course of 10
sessions.
Training in 5-CSRT. The 5-CSRT task was
performed as previously described (Romberg
et al., 2011). A distinct cohort of mice (8–10
months old) was trained in the 5-CSRT task. At
the beginning of each session, the reward tray
was primed with 7 l of milkshake. Each trial
was initiated after the mouse nose poked the
magazine. In this phase, the stimulus was de-
livered after a variable 5–10 s delay (delay pe-
riod), during which the animal was required to
attend to the screen. In case the mouse prema-
turely touched the screen during this delay, the
response was recorded as premature and
the mouse was punished with a 10 s time-out.
The stimulus duration was initially set to 4 s,
followed by a limited holding period of 5 s,
Figure 1. Expression of VAChT in the PFC of VAChT Six3-Cre-flox/flox mice. A, VAChT protein expression in the PFC with represen-
tative immunoblots inset (n 4). B, Release of newly synthesized [ 3H]ACh in PFC slices (n 3). C, qPCR analysis of nAChR
expression (n 6, data are mean SEM, *p 0.05).
Figure 2. VAChTSix3-Cre-flox/flox mice show normal visual discrimination learning. A, Mean number of trials required to reach criteria
during the operant conditioning, pretraining phases. B, Image of a mouse performing the task, with the fan shown as the S and the
marblesastheS.C,Numberofsessionstocriteria inthepairwisevisualdiscrimination learningtask.D,Correctionerrorsmadetoachieve
discrimination criteria.E,Mean response latency. F,Mean reward collection latency.n 8, data aremean SEM.
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during which the stimulus was absent, but the mouse could still respond
to the location (holding period). Responses to the stimulus window dur-
ing stimulus presence or the holding period were recorded as correct and
a 7 l reward was administered, while responses to any other window
were recorded as incorrect. A correct choice was rewarded with a tone
and food delivery. An incorrect response was punished with a 10 s time-
out. A failure to respond to any window either during stimulus display,
or during the holding period, was recorded as an omission and punished
with a 10 s time-out. Perseverative responses to the screen after prema-
ture, correct, and incorrect choices were also recorded. Once the perfor-
mance of a mouse reached criterion at 4 s stimulus duration (80%
accuracy, 20% omissions for 3 consecutive days), the stimulus duration
was reduced to 2 s. After reaching criterion with the 2 s stimulus, mice
were tested for two more days. The mean measurement of those 2 d was
used to assess baseline performance. If the mouse completed30 trials,
it was considered not to have reached criteria, even if it met accuracy and
omissions thresholds.
Probe trial. To probe attention in mice we used a previously described
probe trial schedulewith reduced stimulusdurations (Romberg et al., 2011).
Briefly, each mouse was tested for 2 consecutive days at a given stimulus
duration (1.5, 1, 0.8, and 0.6 s). After each test, the animal was retested onto
the2 s stimulusduration for2doruntil criteriawere reached (80%accuracy,
20% omission), to assess baseline performance. The order of the probe trial
sessions were semirandomized using a Latin square method.
Distraction task.To further test attentional demand, and assess suscep-
tibility to distraction, we developed a distraction version of the 5-CSRT
task. During this task, a 1000 ms distractor tone, different from the
reward tone, was played semirandomly at five
different time points during the delay period: 0
(corresponding towhen themouse initiates the
task), 0.5, 2.5, 4.5, and 5 s (corresponding to
when the stimulus is displayed on the touch-
screens). Stimulus duration was set to 2 s. For
each distractor tone time point mice were
tested for five sessions. At the end of the five
sessions one baseline task (50 trial, 2 s stimulus
duration, no distractor sounds) was performed
before moving to the next distractor time
point.
5-CSRT task measures. On all 5-CSRT task
sessions, accuracy was defined as the total
number of correct responses, divided by the
number of correct and incorrect (touches to a
wrong window while the correct stimulus was
still displayed) responses. The rate of omis-
sions was the proportion of omitted responses
to total trials. Response latencywas the time for
the mouse to touch the correct stimulus after
its onset. Reward collection latency was the
time for the mouse to return to the reward tray
once it had touched the correct stimulus. A
premature response was counted when the
mouse touched one of the windows before
stimulus onset. Finally, a perseverative re-
sponse was any identical response that oc-
curred following a correct, incorrect, or
premature response.
Drug treatment. Galantamine hydrobro-
mide, a cholinesterase inhibitor, (Sigma-
Aldrich) was dissolved in physiological saline
(0.9%NaCl) before administration. Sixtymin-
utes before being tested on the 5-CSRT mice
received an intraperitoneal injection of drug
(100l, 1 mg/kg) or saline. The dose for galan-
tamine was selected based on previous studies
(Prado et al., 2006; de Castro et al., 2009b; De
Jaeger et al., 2013). Previously, we have tested 3
mg/kg galantamine in other tasks, but this dose
was no more effective than 1 mg/kg and it pro-
duced hypersalivation inmice (de Castro et al.,
2009b). Moreover, at 1 mg/kg wild-type mice were able to increase their
performance in the 5-CSRT (see below). Mice were tested at the 0.6 s
stimulus duration, which represents a high attention demanding task
(Romberg et al., 2011). The order of the injections was counterbalanced.
Between injections mice had three washout days wherein their perfor-
mance on the 5CSRT was re-baselined at the 2 s stimulus duration.
Statistical analysis.For the pairwise visual discrimination task response
accuracy was calculated as the number of correct trials divided by the
total number of trials, excluding correction trials. Data are expressed as
mean  SEM. SigmaStat 3.5 software was used for statistical analysis.
Comparison between two experimental groups was made by Student’s t
test or Mann–Whitney rank sum test, when the data did not follow a
normal distribution. When several experimental groups or treatments
were analyzed, two-way ANOVA or two-way ANOVA with repeated
measures was used as required. When appropriate, a Tukey’s HSD post
hoc comparison test was used. In all comparisons, p 0.05 was consid-
ered statistically significant.
Results
VAChTSix3-Cre-flox/flox mice have reduced VAChT and ACh
release in the PFC
We have previously reported that VAChTSix3-Cre-flox/flox mice
have theVAChT gene deleted from90%of their basal forebrain
cholinergic neurons (Martyn et al., 2012). To confirm that this
deletion affected prefrontal cortical cholinergic signaling, we per-
Figure 3. VAChT Six3-Cre-flox/flox mice have impaired reversal learning. A, Image of a mouse performing the task, this time with
the fan shown as the S and the marbles as the S. B, Choice accuracy before (B1 and B2) and during reversal trials (R2–R10),
dashed line denotes chance (50%). C, Number of correction errors made across reversal trials. D, Response latency across reversal
trials.E, Reward collection latency across reversal trials (n8, data aremeanSEM, *p0.05, **p0.01, and***p0.001).
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formed Western blot analysis to assess VAChT expression.
VAChTSix3-Cre-flox/flox mice have a significant reduction in PFC
VAChT protein expression (t(6)  2.706, p  0.0353; Fig. 1A).
Moreover, this reduction in VAChT protein levels results in a
significant decrease in newly synthesized [3H] ACh release in
slices of PFC from VAChTSix3-Cre-flox/flox mice when compared
with control mice (t(4)  2.899, p  0.0442; Fig. 1B). We used
qPCR to assess the expression of nicotinic receptors (nAChRs),
which have been shown previously to be critical for attentional
performance. The PFC of VAChTSix3-Cre-flox/flox mice shows no
significant change in the expression of 7nAChRmRNA (t(10)
0.9300, p  0.3743) nor 2nAChR mRNA (t(10)  0.8359, p 
0.4227). Interestingly, 4nAChR mRNA is slightly upregulated
(t(10) 2.550, p 0.0289; Fig. 1 C).
Decreased forebrain cholinergic tone specifically disturbs
reversal learning in the pairwise visual discrimination task.
We have previously demonstrated that VAChTSix3-Cre-flox/flox
mice have impairments in reversal learning in the MWM
(Martyn et al., 2012), suggesting the possibility that these mice
have behavior flexibility deficits. To determine whether
VAChTSix3-Cre-flox/flox mice present alterations in cognitive flexi-
bility we used a “nonhippocampal” pairwise visual discrimina-
tion task (Romberg et al., 2013). This task has been previously
shown to depend on the PFC and also on striatal-cortical loops
(Graybeal et al., 2011). The performance of VAChTSix3-Cre-flox/flox
mice did not differ from that of controls (VAChTflox/flox) when
they were trained to operate the touchscreen (pretraining phase).
The number of sessions the mice took to acquire each training
phase did not differ from control (RM-ANOVA, no effect of
genotype F(1,54)  0.3950, p  0.5398; main effect of training
phase F(4,54) 5.227, p 0.0012; and no interaction effect F(4,54)
1.389, p 0.2495; Figure 2A). Acquisition of the pairwise visual
discrimination task (Fig. 2B; for stimuli used) did not differ
between genotypes, in terms of sessions to criteria (Fig. 2C; t(14)
0.2446, p  0.8117), correction errors made (Fig. 2D; t(14) 
0.2942, p  0.7746), response latency (Fig. 2E; t(14)  1.019,
p 0.3256), or reward collection latency (Fig. 2F; t(14) 0.2606,
p  0.7988). We have previously reported that these mice are
hyperactive in novel environments, but they are able to habituate
to the environment (Martyn et al., 2012). Hence, due to the ex-
tensive training for the performance in the touchscreen tasks the
lack of differences in response and reward collection latencies is
not surprising. However, VAChTSix3-Cre-flox/flox mice showed se-
vere reversal learning impairment (Fig. 3A; for the stimuli used),
measured by the percentage of correct responses (Fig. 3B; RM-
ANOVA, main effect of genotype F(1,132)  19.78, p  0.0008;
main effect of session F(11,132)  23.28, p  0.0001; and signifi-
cant interaction effect F(1,12)  5.035, p  0.0001) and by its
increased correction errors (Fig. 3C; RM-ANOVA,main effect of
genotype F(1,132)  14.72, p  0.0024; main effect of session
F(11,132)  14.37, p  0.0001; and significant interaction effect
F(1,12)  2.817, p  0.0025). Post hoc analysis showed that
VAChTSix3-Cre-flox/flox mice never improved significantly from
the first reversal session and in 10 sessions they performed only
at chance level. Importantly, during the reversal trials, the
VAChTSix3-Cre-flox/flox mice did not differ from controls in terms
of response latency (Fig. 3D; RM-ANOVA, no effect of genotype
F(1,154)  0.4233, p  0.5258; main effect of session F(11,154) 
4.705, p 0.0001; andno interaction effectF(11,154) 0.9997, p
0.4493) or reward collection latency (Fig. 3E; RM-ANOVA, no
effect of genotype F(1,154)  1.107, p  0.3105; main effect of
session F(11,132)  3.965, p  0.0001; and no interaction effect
F(11,154) 1.141, p 0.3333). These results suggest that forebrain
cholinergic tone is important for cognitive flexibility.
VAChTSix3-Cre-flox/flox mice have impaired acquisition of the
5-CSRT task
Similar to the results for visual discrimination experiments, the
performance of the second cohort of VAChTSix3-Cre-flox/flox mice
did not differ from that of controlmice for touchscreen operation
training (pretraining phase). The number of sessions necessary to
reach criteria across all pretraining phases did not differ between
genotypes (RM-ANOVA, no effect of genotype F(1,32)  1.528,
p 0.2515; no effect of training phase F(4,32) 1.492, p 0.2280;
Figure 4A). However, when mice were trained to respond to
flashes of light displayed in one of the five spatial locations on the
touchscreen (training phase), VAChTSix3-Cre-flox/flox showed a
significantly worse performance, needing more sessions to reach
criteria (RM-ANOVA, main effect of genotype, F(1,8)  10.06,
p 0.0132; main effect of stimulus duration, F(1,8) 5.731, p
0.0436, no interaction effect, F(1,8) 4.252, p 0.0731; Fig. 4B).
Deletion of forebrain VAChT results in inattentive but not
impulsive or compulsive behavior
Once mice reached criteria they were tested for attentional per-
formance by decreasing stimulus duration to 1.5, 1, 0.8, and 0.6 s
as previously described (Romberg et al., 2011). At 1.5 s,
VAChTSix3-Cre-flox/flox mice were able to perform identically to
control mice in both accuracy and omissions (Fig. 5A,B). In
contrast, increasing attentional demand by diminishing the stim-
uli period revealed an attentional deficit in VAChTSix3-Cre-flox/flox
mice. Response accuracy did not differ between genotypes (RM-
ANOVA, no effect of genotype F(1,24)  0.0007548, p  0.9788;
main effect of stimulus duration F(3,24) 10.28, p 0.001; Figure
5A). However, VAChTSix3-Cre-flox/flox mice presented an in-
creased rate of omission (RM-ANOVA, main effect of genotype
F(1,24)  57.99, p  0.0001; main effect of stimulus duration
Figure 4. Training in the 5-CSRT task. A, Mean number of trials required to reach criteria
during the operant conditioning, pretrainingphases.B,Meannumber of trials required to reach
criteria at 4 and 2 s stimulus duration (n 6, data are mean SEM, *p 0.05).
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F(3,24) 36.44, p 0.0001; no interaction effect F(3,24) 2.176,
p  0.1171; Figure 5B). Post hoc analysis revealed that
VAChTSix3-Cre-flox/flox mice omitted more at 0.6–1 s stimulus
durations. Interestingly, VAChT-deficient mice had no
alterations in premature responses (RM-ANOVA, no effect of
genotype F(1,24)  0.07440, p  0.7874; no effect of stimulus
duration F(3,24) 0.9891, p 0.4146; Figure 5C) or perseverative
responses (RM-ANOVA, no effect of genotype F(1,24) 0.04610,
p  0.9695; no effect of stimulus duration F(3,24)  1.244, p 
0.3232; Figure 5D). Additionally, mutant mice did not differ
from littermate controls in response la-
tency (RM-ANOVA, no effect of genotype
F(1,24)  2.279, p  0.1818; no effect of
stimulus duration F(3,24)  0.09686, p 
0.7662; Figure 5E) and reward collection
latency (RM-ANOVA, no effect of geno-
type F(1,24) 2.279, p 0.1818; no effect
of stimulus duration F(3,24)  1.189, p 
0.3420; Figure 5F).
Deletion of forebrain VAChT impairs
sustained attention
To assess sustained attention (vigi-
lance), we analyzed both response accu-
racy and rate of omissions over blocks of
10 trials (Romberg et al., 2011). Re-
sponse accuracy of control mice did not
significantly vary across blocks, but did
reduce significantly with decreases in
stimuli duration (RM-ANOVA, main
effect of stimulus duration F(3,48) 
5.893, p  0.0104; no effect of block
F(4,48) 1.214, p 0.317; Figure 6A). In
contrast, response accuracy of
VAChTSix3-Cre-flox/flox mice reduced sig-
nificantly across blocks and stimuli du-
ration (RM-ANOVA, main effect of
stimulus duration F(3,48)  4.257, p  0.0077; main effect of
block F(4,48) 3.933, p 0.0289; Figure 6B). As with response
accuracy, rate of omissions of control mice did not vary across
blocks, only with stimuli duration (RM-ANOVA, main effect
of stimulus duration F(3,48)  5.803, p  0.0228; no effect of
block F(4,48) 0.5352, p 0.7105; Figure 6C), whereas rate of
omissions of VAChTSix3-Cre-flox/flox mice increased signifi-
cantly across stimuli duration and blocks (RM-ANOVA, main
effect of stimulus duration F(3,48)  9.387, p  0.0018; main
Figure 5. VAChT Six3-Cre-flox/floxmice have attentional deficits. Performance and responsemeasures during 5-CSRT task probe trials. Micewere subjected to a series of probe trials and the average
values of 50 trial sessions are plotted. A, Mean accuracy. B, Mean rate of omissions. C, Mean premature responses. D, Mean perseverative responses. E, Mean response latency. F, Mean reward
collection latency (n 6, data are mean SEM, *p 0.05 and **p 0.01).
Figure 6. VAChT Six3-Cre-flox/flox mice have impaired sustained attention. Mean response accuracy for blocks of 10 trials for (A)
VAChT flox/flox and (B) VAChT Six3-Cre-flox/flox mice. Mean rate of omission for blocks of 10 trials for (C) VAChT flox/flox and (D)
VAChT Six3-Cre-flox/flox mice (n 6, data are mean SEM, *p 0.05).
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effect of block F(4,48)  2.803, p 
0.0360; Figure 6D). Together the data
suggest that VAChTSix3-Cre-flox/flox mice
have impaired ability to sustain
attention.
Deletion of forebrain VAChT increases
susceptibility to distractions
To assess distractibility of VAChTSix3-Cre-flox/
flox mice, we increased attentional demand
by testing themon a distraction variation of
the 5-CSRT. Stimulus duration was set to
2 s, where performance of both genotypes
was identical, and distractor sounds were
played at set time points during trials. Re-
sponse accuracy of VAChTSix3-Cre-flox/flox
mice tended to be reduced by distractions
compared with controls (RM-ANOVA,
near significant effect of genotype F(1,32)
4.825, p 0.0589; main effect of distractor
onset F(4,32)  3.583, p  0.0159; Figure
7A). Rate of omission was significantly
higher in VAChTSix3-Cre-flox/flox mice than
controls (RM-ANOVA, significant effect of
genotype F(1,32) 6.809, p 0.0312; no ef-
fect of distractor onset F(4,32) 2.564, p
0.0572; Figure 7B). Importantly, neither re-
sponse latency (RM-ANOVA, no effect of
genotype F(1,32) 1.045, p 0.3367; main
effect of distractor onset F(4,32) 7.069, p
0.0003; Figure 7C) nor reward collection latency varied between ge-
notypes (RM-ANOVA, no effect of genotype F(1,32) 0.7467, p
0.4127; main effect of distractor onset F(4,32)  3.226, p  0.0248;
Figure 7D).
Galantamine improves attention in wild-type mice on a
demanding task
Detection of pro-attentive effects of pharmacological manipula-
tions on the 5-CSRT is hampered by possible ceiling effects (Rob-
bins, 2002). To detect differences in mice it is important to test
the drug on challenging conditions, which can be achieved by
shortening the duration of the stimulus presentation (Romberg
et al., 2011). To find a suitably challenging task in which we could
observe increased attention, we trained a group (n 8) of wild-
type mice on the 5-CSRT, and ran them through the probe trial
series, serially reducing stimulus duration (1.5, 1, 0.8, and 0.6 s).
Choice accuracy (F(4,31) 13.77, p 0.0001; Fig. 8A) and rate of
omissions (F(4,31) 6.716, p 0.0024; Fig. 8B) were significantly
affected by reducing stimulus duration. Post hoc analysis revealed
that at 0.6 s stimulus duration the rate of accuracy was signifi-
cantly reduced, and omissions significantly increased from the
1.5 s stimulus duration. We therefore chose both, 0.8 s stimulus
duration and the more challenging 0.6 s stimulus duration, for
pharmacological testing. Administration of galantamine (1 mg/
kg, i.p.) 1 h before 5-CSRT testing at 0.8 s did not improve accu-
racy (paired t test, t(7) 1.287, p 0.2544; Fig. 8C) or omissions
(paired t test, t(7) 0.4581, p 0.6661; Fig. 8D). However, when
administered before a 0.6 s stimulus duration session, galan-
tamine (1 mg/kg) significantly improved accuracy compared
with saline (paired t test, t(7)  2.405, p  0.0471; Fig. 8E) and
significantly reduced the rate of omission (paired t test, t(7) 
2.379, p 0.0489;Fig. 8F). Response latency (paired t test, t(7)
1.296, p  0.2360), and reward collection latency (paired t test,
t(7) 0.390, p 0.7080) were not changed by galantamine injec-
tions (data not shown). These results suggest that increased cho-
linergic tone can increase attentional performance when the
probe trial is sufficiently demanding to avoid a potential ceiling
effect.
Galantamine does not improve attention deficits in
VAChTSix3-Cre-flox/flox mice
To investigate if the deficits observed in VAChTSix3-Cre-flox/flox are
exclusively related to decreased levels of synaptic ACh, we in-
jectedmice with galantamine (1mg/Kg IP), a dose that effectively
improved performance of wild-type mice (Fig. 8), and tested
both VAChTSix3-Cre-flox/flox and VAChTflox/flox mice at 0.6 s (50
trials). Galantamine tended to improve choice accuracy, albeit
this effect did not reach statistical significance (paired t test, t(5) 
1.954, p 0.1224; Fig. 8G). However, the drug was able to signifi-
cantly reducerateofomissions (paired t test, t(5)3.383,p0.0277;
Fig. 8H) in VAChTflox/flox mice. Interestingly, galantamine had no
effect on theperformanceofVAChTSix3-Cre-flox/floxmice, neither im-
proving accuracy (paired t test, t(5) 0.162, p 0.880; Fig. 8G) nor
rate of omission (paired t test, t(5) 0.868, p 0.434; Fig. 8H).
Deletion of forebrain VAChT results in metabolic
abnormalities in the PFC
The lack of effect of galantamine in VAChTSix3-Cre-flox/flox sug-
gests that diminished ACh release in mutant mice may not be
sufficiently increased by galantamine to reverse the attentional
deficits in these mice. In addition to that, a chronic decrease in
cholinergic tone may cause circuitry or metabolic changes that
could affect how neuronal circuitries are recruited for specific
cognitive tasks.We used in vivomagnetic resonance spectroscopy
to assess if metabolic parameters were affected in the prefrontal
region ofVAChT-deficientmice (Fig. 9A; representative spectra).
Figure 7. VAChT Six3-Cre-flox/flox mice aremore susceptible to distraction.Micewere subjected to a series of distraction trials and
the average values of 50 trial sessions per distractor onset are plotted. A, Mean response accuracy. B, Mean rate of omission. C,
Mean response latency. D, Mean reward collection latency (n 6, data are mean SEM, * represents significant differences
between genotypes, # represents significant differences within genotypes; *p 0.05).
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This analysis revealed that VAChTSix3-Cre-flox/flox mice had signif-
icantly less Lac (t(6)  2.600, p  0.0428; Fig. 9B) and Tau
(t(6) 2.522, p 0.0452; Fig. 9C) than controls. Levels of NAA
(t(6)  0.0907, p  0.9307; Fig. 9D), Myo (t(6)  0.9598, p 
0.3742; Fig. 9E), and Cho (t(6)  0.1461, p  0.8886; Fig. 9F)
remained unchanged.
Deletion of forebrain VAChT results in altered RNA
metabolism in the PFC
Cholinergic deficits in AD have been proposed to cause major
transcriptome changes via aberrant hnRNPA2/B1 expression
(Berson et al., 2012). hnRNPA2/B1 refers to a family of proteins
that functions as splicing factors andmRNAchaperones (Hoek et
al., 1998; Kamma et al., 1999). This gene family is critical for
regulating alternative splicing in numerous genes involved with
synaptic plasticity and cognition (Berson et al., 2012). Its expres-
sion is severely reduced inAlzheimer brain and appears enhanced
in primarymouse neurons under carbachol induction (Berson et
al., 2012), suggesting cholinergic regulation of hnRNPA2/B1pro-
teins. To determine whether the PFC of VAChTSix3-Cre-flox/flox
shows parallel suppression of the hnRNPA2/B1 proteins, their
levels were assessed. Compared with controls, the PFC of
VAChTSix3-Cre-flox/flox mice showed a significant reduction in hn-
RNPA2/B1 expression (75% decrease, t(6)  4.941, p  0.0026;
Fig. 10A). We then used qPCR to assess whether the decrease in
hnRNPA2/B1 could have a functional impact onRNAprocessing
in the PFC.We evaluated the alternative splicing of the key genes,
SIPA1L1(SIPA), REELIN(RELN), DRAM2, CD55, DYSTONIN
(DST), and ENAH, as manifested by increased exon inclusion
tested both in Alzheimer’s brain and in mouse brain depleted of
its cholinergic neurons by saporin-mediated treatment (Berson
et al., 2012). This analysis revealed that VAChTSix3-Cre-flox/flox
mice had significant changes in the splicing of these genes in the
PFC, with significantly increased inclusion of exon 8 of CD55
(t(10)  2.550, p  0.0289), exon 41 of DST (t(10)  7.436, p 
0.0001), exon 18 of RELN (t(10) 3.230, p 0.0090), and exon 2
of DRAM2 (t(10)  3.990, p  0.0260). In addition the inv iso-
form of the ENAH gene was also significantly increased (t(10) 
2.522, p 0.0303). In contrast, intron 5 of SIPA (t(10) 0.5449, p
0.5978) and exon 3 of RELN (t(10) 2.215, p 0.0511), which have
also been shown to be affected inAD,were unchanged, althoughwe
detected a trend for the latter (Fig. 10B).
hnRNPA2/B1 has been shown to regulate the splicing of
pyruvate kinase M (PKM) enzyme, which in turn dictates lac-
tate metabolism (David et al., 2010). Knockdown of hn-
RNPA2/B1 expression in vitro favors the PKM1 isoform,
which leads to reduced levels of Lac, whereas upregulation
hnRNPA2/B1 favors the PKM2 isoform and increased Lac lev-
els (Clower et al., 2010; for review, see Chen et al., 2010). To
test whether alternative splicing of PKM occurs in VAChTSix3-
Cre-flox/flox mice, we performed qPCR to determine the expression
of the PKM1 and PKM2 splice variants. Interestingly the
VAChTSix3-Cre-flox/flox mice showed a significant upregulation of
the PKM1 variant (t(10)  4.277, p  0.0016), and a significant
reduction in the PKM2 variant (t(10)  3.073, p  0.0110; Fig.
10C), effectively changing the ratio between these two enzymes.
Figure 8. Galantamine improves attention in wild-type, but not in VAChT Six3-Cre-flox/flox mice. Wild-typemice (n 8) were subjected to a series of probe trials and the average values of 50 trial
sessions are plotted.A, Mean accuracy.B, Mean rate of omissions. Effect of galantamine (1mg/kg i.p.) on (C) response accuracy and (D) rate of omission inwild-typemice at a 0.8 s stimulus duration
(n 8). Effect of galantamine on (E) response accuracy and (F ) rate of omission in wild-type mice at a 0.6 s stimulus duration (n 8). Effect of galantamine (1 mg/Kg I.P.) on (G) choice accuracy
and (H ) rate of omission in VAChT flox/flox and VAChT Six3-Cre-flox/flox mice (n 6, data are mean SEM, *p 0.05).
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Discussion
In this report we show that forebrain
VAChT knock-out mice present deficits
in two domains of executive function,
cognitive flexibility and attention. Addi-
tionally, VAChT-deficient mice exhibit
metabolic deficits in the PFC suggestive of
changes in PFC circuitry. Furthermore,
these mice have reduced expression of a
key splicing factor, hnRNPA2/B1, which
has been previously implicated in synaptic
plasticity deficits in AD (Berson et al.,
2012) and in mutations that were recently
discovered in rare proteinopathies (Kim
et al., 2013). These changes have a func-
tional impact on RNA metabolism in the
PFC of VAChT-deficient mice. These re-
sults suggest that VAChTSix3-Cre-flox/flox
micemay represent a powerful tool to dis-
sect the molecular and neurochemical ba-
sis of executive dysfunction.
Cognitive flexibility in
VAChTSix3-Cre-flox/flox mice
VAChTSix3-Cre-flox/flox mice were able to
associate an image with a reward, and an-
other with a punishment, in the pairwise
visual discrimination task. Acquisition of
this task has been shown to be dependent
on glutamatergic signaling, with mice
lacking the GLAST glutamate transporter
being unable to acquire the task (Karlsson
et al., 2009). Evidence suggests that the
NMDA receptor is an important molecu-
lar switch for the acquisition of the task
(Brigman et al., 2008; Barkus et al., 2012).
Our results indicate that cholinergic sig-
naling is not required for such learning. In contrast, when con-
tingencies of the pairwise task were reversed, forebrain VAChT
knock-out mice were unable to adapt and learn the new rule.
Reversal learning in a visual discrimination task has been pro-
posed to serve as a measure of cognitive flexibility in rodents
(Izquierdo et al., 2006; Brigman et al., 2008). Neurochemical
modulation of reversal learning is complex, as it can be en-
hanced by targetingmultiple neurotransmitter signaling systems in-
cluding serotonergic (Brigman et al., 2010), dopaminergic
(Izquierdo et al., 2006), and glutamatergic (Balschun et al., 2010).
The roleof cholinergic signalinghasbeen focusedpredominantlyon
muscarinic receptors (Ridley et al., 1984, 1985). Determining the
exactmechanismhasbeendifficult, asM1receptoragonists facilitate
cognitive flexibility (McCool et al., 2008; Shirey et al., 2009), but no
effects on cognitive flexibility were observed in M1-null mice
(Bartko et al., 2011). There is evidence suggesting that M2 and M4
receptors may be involved in cognitive flexibility (Nieves-Martinez
et al., 2012). Our results indicate that cholinergic signaling is essen-
tial for modulation of cognitive flexibility.
Attention deficits in VAChT-deficient mice
To further understand the role of forebrain ACh in executive func-
tion we evaluated attention on forebrain VAChT knock-out
mice using the 5-CSRT task, a test suggested to be dependent on
PFC cholinergic signaling (Guillem et al., 2011; for review, see
Robbins, 2000; Dalley et al., 2004a). In line with our previous
finding with the VAChTSix3-Cre-flox/flox mouse line having learn-
ing andmemory deficits (Martyn et al., 2012), thesemice showed
impairments in acquisition of the 5-CSRT, taking nearly twice as
long as controls to reach criteria at the 4 and 2 s phase of the
training process. Interestingly, they were not impaired during the
pretraining phase, wherein mice are taught to respond to the
touchscreen. These results suggest that simple operant condi-
tioning is not dependent on forebrain cholinergic signaling, but
rather that forebrain ACh is responsible for the use of such infor-
mation to perform higher order cognitive tasks. Attentional de-
mand deficits were probed by reducing stimulus duration.
Choice accuracy, perseverative, and premature responses of
VAChTSix3-Cre-flox/flox mice were unaffected. However, the rate
of omission for VAChTSix3-Cre-flox/flox was significantly in-
creased. Additionally, in the presence of a noise distractor
VAChTSix3-Cre-flox/flox mice were significantly less attentive than
controls, showing a much higher rate of omissions. This test was
performed under a condition in which the performance of
VAChT-deficient mice was on par with controls without the au-
ditory distraction. The auditory distraction task gives a clear in-
dication that the attention deficits observed in VAChTSix3-Cre-
flox/flox mice were not due to visual abnormalities. These findings
are aligned with previous work, given that cue detection has been
shown to involve transient rises in ACh release (Himmelheber et
al., 2000; Parikh et al., 2007). Our experiments agree with previ-
ous work indicating a key role for cholinergic activity in improv-
Figure 9. VAChT Six3-Cre-flox/flox mice have metabolic abnormalities in the PFC. In vivo magnetic resonance spectroscopy of
neuronal metabolites. A, 9.4 tesla 1H magnetic resonance spectroscopy data from VAChT flox/flox (top) and VAhT six3cre-flox/flox
(bottom) mice. The VAChT flox/flox data are shown in gray with fit superimposed (black line) and residual shown above. Individual
component spectra for Tau and Lac are also provided.B, Levels of Lac. C, Levels of Tau.D, Levels of NAA. E, Levels of Myo. F, Levels
of Cho (n 4, data shown are the median and individual values per mouse, *p 0.05).
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ing response to distractors in attentional
tasks (Gill et al., 2000; Terry et al., 2002;
Newman and McGaughy, 2008; Brous-
sard et al., 2009; Howe et al., 2010; St Pe-
ters et al., 2011).
Regulation of attentional performance
by endogenous ACh has been investigated
in rats using immunolesion with IgG-192
saporin (Walsh et al., 1996; Risbrough et al.,
2002; Lehmann et al., 2003; Chudasama et
al., 2004; Dalley et al., 2004b). Specifically,
deficits in choice accuracy and increases in
perseverative responses were observed in
rats following 192 IgG-saporin-induced le-
sions (McGaughy et al., 2002; Dalley et al.,
2004b). In these studies no effects were ob-
served on rates of omissions. Our experi-
ments show a somewhat distinct feature,
demonstrating increased rates of omission,
without changes in perseverative response.
Interestingly, selective elimination of the2
nAChR in mice also revealed an increase in
rate of omissions (Guillem et al., 2011). The
differences between genetically modified
and lesioned animals could therefore be
species related. Alternatively, this difference
may reflect the capacity of cholinergic neu-
rons to secrete more than one neurotrans-
mitter (El Mestikawy et al., 2011; Prado et
al., 2013). Basal forebrain cholinergic neu-
rons can release glutamate in vitro (Allen et
al., 2006). There is also evidence that these
neurons possess the machinery to release
GABA (Henny and Jones, 2008). Recent ex-
periments targeting striatum cholinergic
neurons revealed striking behavioral differ-
ences between mice that had cholinergic
elimination, using immunolesion, or mice
that were genetically targeted to eliminate
striatal ACh release (Kitabatake et al., 2003;
Guzman et al., 2011; for review, see Prado et
al., 2013). Immunolesion of cholinergic
neurons can therefore have effects beyond
impairing ACh release and could affect
cotransmission. Whether cotransmission
has a role in the small phenotypic differ-
ences between our experiments and previ-
ous work using rats injected with IgG-192-
saporin remains to be determined.
Alterations in PFC function in VAChT-
deficient mice
Galantamine was unable to rescue the at-
tention deficits in VAChTSix3-Cre-flox/flox
mice. We have previously shown, using a
mouse line with decreased VAChT ex-
pression, that galantamine could reverse
social memory deficits (Prado et al., 2006)
and object recognition memory deficits
(de Castro et al., 2009b; De Jaeger et al.,
2013). Hence, the fact that galantamine can
improve performance of control mice, but
not of VAChTSix3-Cre-flox/flox mice, suggests
Figure 10. VAChT Six3-Cre-flox/flox mice have abnormal RNA processing in the PFC. A, hnRNPA2/B1 protein expression in
the PFC with representative immunoblots (inset, n 4). B, qPCR analysis of alternative splicing events for CD55, ENAH,
SIPA, Dystonin (DST), Reelin (RELN), and DRAM2. C, Expression of the PKM1 and PKM2 isoforms. Alternative exon levels are
normalized to a constitutive exon from the same gene (n  6, data are mean  SEM, *p  0.05, **p  0.01, and
***p 0.001).
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that the latter may not release sufficient synaptic ACh to be en-
hanced by galantamine. Alternatively, these sophisticated tasks
may be more affected by changes in neuronal circuitry. The in
vivo 1H spectroscopy data suggest that critical metabolic changes
occur in VAChT-deficient mice; namely, reduced levels of both
Tau and Lac in the prefrontal region. Lac has been proposed as
the preferred metabolic substrate for neurons (for review, see
Pellerin et al., 2007), suggesting that decreased cholinergic tone
may lead to a general decrease in neuronal activity.
The reduction in PFC hnRNPA2/B1 observed in
VAChTSix3-Cre-flox/flox mice is in line with previous work indicating
cholinergic-mediated regulation of its expression in AD (Berson et
al., 2012). Furthermore, we found that alternative splicing alteration
pattern in the PFC of these mice is similar to the pattern found in
both AD patient samples and hypocholinergic animal models (Ber-
sonet al., 2012).Overall, these changes suggest alterations in thePFC
circuitry. Furthermore, the splicing change found in the PKM gene
indicates a potential mechanism for cholinergic regulation of Lac
metabolism.Of note, nearly significant differential expression of the
PKMvariants was observed in exon array datasets from the entorhi-
nal cortices of threeADpatients and threematched controls studied
previously, despite the small number of samples (Berson et al., 2012;
p 0.051; raw data deposited in the GenBank).
Decreased Lac levels have been observed in mouse models of
AD (DuYan et al., 2000;Marjanska et al., 2005).Moreover, in the
CRND8 transgenic mouse model of AD, lower levels of Tau were
observed in vivo by H1-NMR (Salek et al., 2010). Interestingly,
high levels of Lac in cultured neurons decrease susceptibility to
A-derived peptides and oxidative stress in vitro (Newington et
al., 2012). Together, these data suggest that VAChTSix3-Cre-flox/flox
mice may be useful for understanding metabolic abnormalities
that occur in dementia.
Conclusion
In summary, by eliminating VAChT from the forebrain we de-
termined that cholinergic signaling regulates executive function,
affects metabolism, and also RNA processing in the PFC. The
PFC has been shown to mediate salient cue detection (Himmel-
heber et al., 2000; Parikh et al., 2007), and it serves as a hub that
regulates numerous neurotransmitter interactions (Dalley et al.,
2004a; Carr et al., 2007; Tait andBrown, 2008).Ourwork helps to
define the specific role played by ACh in behaviors related to
cortical functioning, and its potential underlying mechanisms.
Decreased levels of VAChT in the brain have been reported in AD
(Efange et al., 1997; Chen et al., 2011), therefore the executive
dysfunction andmRNAprocessing abnormalities we observed in
VAChT-deficient mice may be of relevance to model this specific
deficiency in humans. Therefore, this work provides novel in-
sights into the basic neurochemical contributors governing exec-
utive function.
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